These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12014241)

  • 1. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
    Vergouwen AC; Bakker A
    Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine: a review of clinical experience.
    Dunner D; Kumar R
    Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
    Krol DG; Nolen WA
    Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis after paroxetine treatment.
    Ahmed R; Eagleton C
    N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation of treatment of depression in primary care setting in first week - what happens in first week of treatment with antidepressants?
    Dernovsek MZ; Tavcar R; Sajovic M
    Psychiatr Danub; 2008 Jun; 20(2):227-30. PubMed ID: 18587295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 8. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK; McKenzie J; Worrall N
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of mania in depression by paroxetine.
    Morishita S; Arita S
    Hum Psychopharmacol; 2003 Oct; 18(7):565-8. PubMed ID: 14533140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of controlled-release paroxetine.
    Golden RN
    Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paroxetine in the treatment of depressive disorders (pilot study)].
    Svestka J; Novotný V; Kamenická V; Obrovská V; Cesková E
    Cesk Psychiatr; 1995 Jul; 91(3):135-42. PubMed ID: 7553946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary dermatologic effects of serotonin reuptake inhibitor antidepressants: hypothesis of cross-reacting allergy. Apropos of 2 cases].
    Beauquier B; Fahs H
    Encephale; 1998; 24(1):62-4. PubMed ID: 9559306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine-associated hypereosinophilia may clinically resemble a panic attack.
    Yasui-Furukori N; Sato Y; Kato H; Kaneko S
    Clin Neuropharmacol; 2012; 35(1):47-8. PubMed ID: 22240860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alopecia due to Seroxat therapy].
    Umansky L; Dorevitch A; Sella A
    Harefuah; 2000 Apr; 138(7):547-9, 614. PubMed ID: 10883182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome after lithium add-on medication to paroxetine.
    Sobanski T; Bagli M; Laux G; Rao ML
    Pharmacopsychiatry; 1997 May; 30(3):106-7. PubMed ID: 9211572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study.
    Pae CU; Kim YJ; Won WY; Kim HJ; Lee S; Lee CU; Lee SJ; Kim DW; Lee C; Min WS; Kim CC; Paik IH; Serretti A
    Hum Psychopharmacol; 2004 Jan; 19(1):25-9. PubMed ID: 14716708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
    Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paxil and self-scratching.
    Weintrob A
    J Am Acad Child Adolesc Psychiatry; 2001 Jan; 40(1):5. PubMed ID: 11195562
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.
    Kraus RP
    Depression; 1996; 4(2):92-4. PubMed ID: 9160648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.